Porto Edoardo, Fiore Giorgio, Casali Cecilia, Stanziano Mario, Broggi Morgan, Bertani Giulio A, Marcus Hani J, Locatelli Marco, DiMeco Francesco
Department of Neurosurgery, Fondazione IRCCS Istituto Neurologico Carlo Besta, 20133 Milan, Italy.
Department of Neurosurgery, Emory University, Atlanta, GA 30322, USA.
J Clin Med. 2025 Jun 25;14(13):4488. doi: 10.3390/jcm14134488.
The surgical management of trigeminal schwannomas (TSs) has evolved considerably, with increasing interest in minimally invasive approaches. We performed a meta-regression analysis to characterise temporal trends in surgical strategies for TS and to explore factors influencing outcomes. This systematic review and meta-regression followed the PRISMA 2020 guidelines. Comparative studies published in English reporting surgical treatment of TS were included. Outcomes assessed were the extent of resection (EOR), improvement or worsening of trigeminal symptoms, and postoperative complications. Meta-analyses of pooled frequencies were performed, and meta-regression analyses evaluated associations between surgical approach, tumour localization, year of publication, and outcomes. Surgical approaches were categorized as microsurgical antero-lateral (M-AL-Apr), retrosigmoid (RSA), endoscopic endonasal (EEA), and endoscopic transorbital (ETOA). Tumour localization was stratified using the Samii classification. Fifteen studies (583 surgeries) were included. Endoscopic approaches accounted for 20.1% of cases, with increasing use over time (β = 0.12- < 0.001), largely driven by transorbital access for Samii type A and C tumours. The use of M-AL-Apr declined. The pooled gross-total resection (GTR) rate was 73% (I = 78.8%). The stratified meta-regression identified a temporal decrease in GTR for Samii type C tumours alone, while resection rates for types A, B, and D remained stable, likely reflecting the increasing proportion of anatomically complex cases in recent series Trigeminal impairment improved postoperatively in 17% (I = 84.5%), while worsening of trigeminal symptoms was rare (β = 0.07%-I = 0%). Complication rates were 11.6% (I = 32.7%) but with a temporal increase (β = 0.041, = 0.047). Tumour type was the dominant predictor of EOR, functional outcomes, and complications. Surgical management of TS has evolved towards minimally invasive techniques, particularly endoscopic routes, reflecting advances in technology and a focus on functional preservation. Tumour anatomy remains the key determinant of surgical outcomes, highlighting the importance of tailored, anatomy-driven surgical planning.
三叉神经鞘瘤(TSs)的手术治疗方法有了很大的发展,人们对微创方法的兴趣日益浓厚。我们进行了一项meta回归分析,以描述TS手术策略的时间趋势,并探索影响手术结果的因素。本系统评价和meta回归遵循PRISMA 2020指南。纳入了以英文发表的关于TS手术治疗的比较研究。评估的结果包括切除范围(EOR)、三叉神经症状的改善或恶化以及术后并发症。对汇总频率进行了meta分析,meta回归分析评估了手术方式、肿瘤定位、发表年份和结果之间的关联。手术方式分为显微外科前外侧入路(M-AL-Apr)、乙状窦后入路(RSA)、鼻内镜入路(EEA)和经眶内镜入路(ETOA)。肿瘤定位采用Samii分类法进行分层。纳入了十五项研究(583例手术)。内镜手术占病例的20.1%,且随着时间的推移使用增加(β = 0.12-<0.001),这主要是由Samii A型和C型肿瘤的经眶入路推动的。M-AL-Apr的使用有所下降。汇总的全切除(GTR)率为73%(I = 78.8%)。分层meta回归显示,仅Samii C型肿瘤的GTR随时间下降,而A、B和D型肿瘤的切除率保持稳定,这可能反映了近期系列中解剖结构复杂病例的比例增加。术后三叉神经功能障碍改善的比例为17%(I = 84.5%),而三叉神经症状恶化的情况很少见(β = 0.07%-I = 0%)。并发症发生率为11.6%(I = 32.7%),但随时间增加(β = 0.041,P = 0.047)。肿瘤类型是EOR、功能结果和并发症的主要预测因素。TS的手术治疗已朝着微创技术发展,特别是内镜手术路径,这反映了技术的进步以及对功能保留的关注。肿瘤解剖结构仍然是手术结果的关键决定因素,凸显了量身定制、以解剖结构为导向的手术规划的重要性。